- Home
- Publications
- Publication Search
- Publication Details
Title
Trends in discovery of new drugs for tuberculosis therapy
Authors
Keywords
-
Journal
JOURNAL OF ANTIBIOTICS
Volume 67, Issue 9, Pages 655-659
Publisher
Springer Nature
Online
2014-08-06
DOI
10.1038/ja.2014.109
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bedaquiline
- (2014) Elias B. Chahine et al. ANNALS OF PHARMACOTHERAPY
- New Approaches to Target the Mycolic Acid Biosynthesis Pathway for the Development of Tuberculosis Therapeutics
- (2014) E. North et al. CURRENT PHARMACEUTICAL DESIGN
- Towards a new combination therapy for tuberculosis with next generation benzothiazinones
- (2014) V. Makarov et al. EMBO Molecular Medicine
- An update on the use of rifapentine for tuberculosis therapy
- (2014) John Gar Yan Chan et al. Expert Opinion on Drug Delivery
- A review of tuberculosis: Focus on bedaquiline
- (2013) B. Chan et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- The DprE1 enzyme, one of the most vulnerable targets of Mycobacterium tuberculosis
- (2013) Giovanna Riccardi et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Clinical Benefit of Delamanid (OPC-67683) in the Treatment of Multidrug-Resistant Tuberculosis Patients in China
- (2013) Qing Zhang et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Tuberculosis Clinical Trial Update and the Current Anti-Tuberculosis Drug Portfolio
- (2013) Juan Palomino et al. CURRENT MEDICINAL CHEMISTRY
- Treatment of pulmonary tuberculosis
- (2013) Andrew Nunn et al. CURRENT OPINION IN PULMONARY MEDICINE
- Vaccine Development for Tuberculosis: Current Progress
- (2013) Ian M. Orme DRUGS
- Synthesis of 3-heteryl substituted pyrrolidine-2,5-diones via catalytic Michael reaction and evaluation of their inhibitory activity against InhA and Mycobacterium tuberculosis
- (2013) Tetiana Matviiuk et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- In vitrosusceptibility testing and totally drug-resistant tuberculosis
- (2013) Giovanni Sotgiu et al. EUROPEAN RESPIRATORY JOURNAL
- TheMycobacterium tuberculosisSecreted Protein Rv0203 Transfers Heme to Membrane Proteins MmpL3 and MmpL11
- (2013) Cedric P. Owens et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Multi-drug-resistant tuberculosis in HIV positive patients in Eastern Europe
- (2013) Frank A. Post et al. JOURNAL OF INFECTION
- Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious in Vivo
- (2013) Pravin S. Shirude et al. JOURNAL OF MEDICINAL CHEMISTRY
- Epidemiology: A mortal foe
- (2013) Tom Paulson NATURE
- Advances in the development of new tuberculosis drugs and treatment regimens
- (2013) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Improved BM212 MmpL3 Inhibitor Analogue Shows Efficacy in Acute Murine Model of Tuberculosis Infection
- (2013) Giovanna Poce et al. PLoS One
- Identification of a small molecule with activity against drug-resistant and persistent tuberculosis
- (2013) F. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Indoleamides are active against drug-resistant Mycobacterium tuberculosis
- (2013) Shichun Lun et al. Nature Communications
- Resistance in tuberculosis: what do we know and where can we go?
- (2013) Keith D. Green et al. Frontiers in Microbiology
- Identification of Novel Inhibitors of M. tuberculosis Growth Using Whole Cell Based High-Throughput Screening
- (2012) Sarah A. Stanley et al. ACS Chemical Biology
- In VitroCombination Studies of Benzothiazinone Lead Compound BTZ043 against Mycobacterium tuberculosis
- (2012) Benoit Lechartier et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis
- (2012) Kapil Tahlan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Totally Drug-Resistant and Extremely Drug-Resistant Tuberculosis: The Same Disease?
- (2012) G. B. Migliori et al. CLINICAL INFECTIOUS DISEASES
- Safety and Pharmacokinetics of Escalating Daily Doses of the Antituberculosis Drug Rifapentine in Healthy Volunteers
- (2012) K E Dooley et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Towards a new tuberculosis drug: pyridomycin - nature's isoniazid
- (2012) Ruben C. Hartkoorn et al. EMBO Molecular Medicine
- Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action
- (2012) Katherine A Sacksteder et al. Future Microbiology
- New Drugs for the Treatment of Tuberculosis: Needs, Challenges, Promise, and Prospects for the Future
- (2012) Christian Lienhardt et al. JOURNAL OF INFECTIOUS DISEASES
- Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane
- (2012) Anna E Grzegorzewicz et al. Nature Chemical Biology
- Delamanid for Multidrug-Resistant Pulmonary Tuberculosis
- (2012) Maria Tarcela Gler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by benzothiazinone inhibitors
- (2012) S. M. Batt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium tuberculosis
- (2012) J. Neres et al. Science Translational Medicine
- MmpL3 Is the Cellular Target of the Antitubercular Pyrrole Derivative BM212
- (2011) Valentina La Rosa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Totally Drug-Resistant Tuberculosis in India
- (2011) Z. F. Udwadia et al. CLINICAL INFECTIOUS DISEASES
- Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
- (2011) J. F. Scheid et al. SCIENCE
- Clinical Isolates of Mycobacterium tuberculosis in Four European Hospitals Are Uniformly Susceptible to Benzothiazinones
- (2010) M. R. Pasca et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Early Bactericidal Activity and Pharmacokinetics of PA-824 in Smear-Positive Tuberculosis Patients
- (2010) A. H. Diacon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Leads for antitubercular compounds from kinase inhibitor library screens
- (2010) Sophie Magnet et al. TUBERCULOSIS
- Triclosan Derivatives: Towards Potent Inhibitors of Drug-Sensitive and Drug-ResistantMycobacterium tuberculosis
- (2009) Joel S. Freundlich et al. ChemMedChem
- Emergence of New Forms of Totally Drug-Resistant Tuberculosis Bacilli
- (2009) Ali Akbar Velayati et al. CHEST
- Structure, function and inhibition of RND efflux pumps in Gram-negative bacteria: an update
- (2009) Jessica MA Blair et al. CURRENT OPINION IN MICROBIOLOGY
- Mycobacterium tuberculosis: drug resistance and future perspectives
- (2009) Giovanna Riccardi et al. Future Microbiology
- Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
- (2009) V. Makarov et al. SCIENCE
- High Content Screening Identifies Decaprenyl-Phosphoribose 2′ Epimerase as a Target for Intracellular Antimycobacterial Inhibitors
- (2009) Thierry Christophe et al. PLoS Pathogens
- Selectivity of TMC207 towards Mycobacterial ATP Synthase Compared with That towards the Eukaryotic Homologue
- (2008) A. C. Haagsma et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The RNA Polymerase “Switch Region” Is a Target for Inhibitors
- (2008) Jayanta Mukhopadhyay et al. CELL
- Biosynthesis of D-arabinose in mycobacteria - a novel bacterial pathway with implications for antimycobacterial therapy
- (2008) Beata A. Wolucka FEBS Journal
- PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
- (2008) R. Singh et al. SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started